Tg(tetO-AGTR1*N111G,-lacZ)1Aco
Transgene Detail
|
Symbol: |
Tg(tetO-AGTR1*N111G,-lacZ)1Aco |
Name: |
transgene insertion 1, Justin Ainscough |
MGI ID: |
MGI:5648211 |
Synonyms: |
hAT1R-mut1 |
Transgene: |
Tg(tetO-AGTR1*N111G,-lacZ)1Aco Location: unknown
|
Alliance: |
Tg(tetO-AGTR1*N111G,-lacZ)1Aco page
|
|
Strain of Origin: |
(CBA x C57BL/6)
|
|
Transgene Type: |
|
Transgenic (Inducible, Inserted expressed sequence, Reporter) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Tg(tetO-AGTR1*N111G,-lacZ)1Aco expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
AGTR1 (185) |
|
|
|
|
|
Mutation details: Transgenic mice with inducible cardiomyocyte-specific expression of an N111G mutant form of the human angiotensin II (Ang II) type-1 receptor (hAT1R) showed strong cardiomyocyte-specific LacZ activation in both neonatal and adult hearts, and pulmonary veins when induced. When adults were given dox, the receptor expression was repressed.
(J:162208)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:162208 Ainscough JF, et al., Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovasc Res. 2009 Feb 15;81(3):592-600 |
All: |
2 reference(s) |
|